Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance

Area of Science:

• Microbiology
• Immunology
• Pathogenesis

Background:

• Mucosal pathogens like Streptococcus pneumoniae utilize polysaccharide capsules for pathogenicity.
• The capsule's role in immune evasion (opsonization, phagocytosis) is known for invasive infections.
• The capsule's function during mucosal colonization, the commensal state, is not well understood.

Purpose of the Study:

• To investigate the role of the polysaccharide capsule in Streptococcus pneumoniae nasal colonization.
• To determine if capsule influences bacterial interaction with mucus and host tissues.

Main Methods:

• Utilized a mouse model to compare encapsulated and unencapsulated Streptococcus pneumoniae strains.
• Assessed bacterial colonization density and duration.
• Performed in vitro binding assays with human airway mucus.
• Investigated the effect of capsule charge and neuraminidase treatment on mucus binding.

Main Results:

• Unencapsulated mutants showed reduced nasal colonization density and duration compared to encapsulated strains.
• This colonization deficit was not due to increased opsonophagocytic clearance.
• Unencapsulated bacteria aggregated in mucus, hindering epithelial surface transit.
• Encapsulation inhibited in vitro binding to mucus, an effect dependent on capsule's negative charge (sialic acid).

Conclusions:

• The polysaccharide capsule of Streptococcus pneumoniae facilitates mucosal colonization by preventing entrapment within lumenal mucus.
• This anti-adhesive property is distinct from the capsule's known role in evading opsonophagocytosis.
• Capsule-mediated electrostatic repulsion likely explains the prevalence of anionic polysaccharides in mucosal pathogens.